All product information provided is intended for U.S. healthcare professionals only. If you are not a healthcare professional and would like more information about any of these products, please contact your doctor. These products may not be available in countries outside the United States or may be available under a different trademark; in different strengths; or for different indications. Countries outside the United States may have different regulatory requirements that would call for different information to be available; product information for countries other than the United States is not available at this time.
For an overview of Elan's research and development program, please click here.
For more information about Elan's pipeline and products, please click here.
| U.S. Products | |
![]() | Tysabri® (natalizumab)
» Tysabri Information Center » Pipeline and Products |
![]() | PRIALT® (ziconotide intrathecal infusion)
» Fact Sheet » Prescribing Information » Pipeline and Products |
![]() | Azactam®(aztreonam for injection, USP) » Fact Sheet » Prescribing Information » Pipeline and Products |
![]() | Maxipime®(cefepime hydrochloride) for Injection |
Elan has a Patient Assistance Program to provide TYSABRI and PRIALT to patients who might not otherwise be able to afford them. For more information on Elan's Medical Needs Program, you may contact the following: TYSABRI at 1-888-489-7227 or PRIALT at 1-888-774-2581
Copyright © 2001- 2004 Elan Corporation, plc, Dublin, Ireland. All rights reserved. | Privacy Policy | Terms of use